FeesSafety
Pluang+

Palatin advances next-gen MC4R obesity drugs with Phase 1 trials planned for 2027, boosting R&D spending.

Company Fundamentals
17 Nov 2026, 14:30 WIB
PRNewsWire
View Source
Bullish
Palatin advances next-gen MC4R obesity drugs with Phase 1 trials planned for 2027, boosting R&D spending.

Palatin Technologies is progressing its next-generation MC4R-selective obesity treatments, targeting Phase 1 clinical trials in 2027 for both long-acting peptide and oral small-molecule candidates. These therapies aim to improve efficacy, tolerability, and dosing convenience while reducing side effects like hyperpigmentation. The company doubled its R&D investment in these programs in Q1 2027 and continues to explore strategic partnerships and additional oral peptide approaches. Financially, Palatin reported a net loss of $5.1 million for the quarter and plans to seek further funding to support ongoing development.

Palatin Technologies' fiscal first quarter 2027 results provide context for readers. For those tracking health-sector stocks, 51 of 150 priced US stocks rose while 91 fell. Notable movers include Elevance Health Inc. at USD 438.01 with a -1.85% change, Aveanna Healthcare Holdings Inc. at USD 11.84 with a +1.81% change, and Alumis Inc. at USD 5.05 with a -1.75% change and 100% sell order activity. Data is as of Nov 17, 2026 18:51 WIB.

More News

Adagene and City of Hope launch Phase 1 trial for new colorectal cancer combo therapy.

Adagene and City of Hope launch Phase 1 trial for new colorectal cancer combo therapy.

Adagene Inc. and City of Hope have started a Phase 1 clinical trial testing a new combination therapy for metastatic colorectal cancer patients resistant to standard treatments. The trial evaluates two experimental drugs, ivonescimab and muzastotug (...

Others
Bullish
58 minutes ago
Provident Bank appoints three leaders to boost commercial banking growth and services.

Provident Bank appoints three leaders to boost commercial banking growth and services.

Provident Bank announced three key leadership appointments to strengthen its Commercial Banking division. Edward Galan will lead Middle Market Lending, Dawn Scocco will manage portfolio and credit risk, and John Maio will head Treasury Management Ser...

Market News
Bullish
58 minutes ago
RoyaLand launches its first mobile game Palazzo Chronicles: Match 3 on Google Play.

RoyaLand launches its first mobile game Palazzo Chronicles: Match 3 on Google Play.

RoyaLand Company Ltd. has released its first mobile game, Palazzo Chronicles: Match 3, on the Google Play Store. The free-to-play match-3 puzzle game features over 270 levels where players restore a royal palace set in Risorgimento Italy. This launch...

Others
Bullish
58 minutes ago
Atiq Khan joins Dune as Director of Engineering to lead real-time onchain market data development.

Atiq Khan joins Dune as Director of Engineering to lead real-time onchain market data development.

Atiq Khan, with over 25 years in financial technology including roles at Goldman Sachs and Coinbase, has joined Dune as Director of Engineering. He will lead the engineering efforts behind Dune Market Data Feeds, which provide real-time trade and liq...

Others
Bullish
58 minutes ago
BlackRock increases voting rights in ICG PLC to 5.16% as of November 13, 2026

BlackRock increases voting rights in ICG PLC to 5.16% as of November 13, 2026

BlackRock, Inc. has increased its total voting rights in ICG PLC to 5.16% as of November 13, 2026, up from 5.17% previously reported. This includes 5.08% voting rights attached to shares and 0.08% through financial instruments. The notification was o...

Market News
Neutral
58 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App